Pakistani (KSE) Healthcare Sector Analysis
UpdatedApr 24, 2024
DataAggregated Company Financials
Companies13
- 7D1.6%
- 3M13.7%
- 1Y35.3%
- YTD8.7%
In the last week, the Healthcare industry is up 1.6%, with GlaxoSmithKline Pakistan up 9.2%. In the last 12 months, the industry was up 35%. Looking forward, earnings are forecast to grow by 38% annually.
Sector Valuation and Performance
Has the Pakistani Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 24 Apr 2024 | PK₨206.6b | PK₨257.0b | PK₨8.2b | 19.9x | 25.1x | 0.8x |
| Fri, 22 Mar 2024 | PK₨184.0b | PK₨252.3b | PK₨8.0b | 12.4x | 23x | 0.7x |
| Sun, 18 Feb 2024 | PK₨172.5b | PK₨248.2b | PK₨7.9b | 12.2x | 21.9x | 0.7x |
| Tue, 16 Jan 2024 | PK₨183.7b | PK₨248.2b | PK₨7.9b | 13.3x | 23.3x | 0.7x |
| Thu, 14 Dec 2023 | PK₨194.1b | PK₨248.2b | PK₨7.9b | 14.9x | 24.6x | 0.8x |
| Sat, 11 Nov 2023 | PK₨164.0b | PK₨245.1b | PK₨7.8b | 12.6x | 21.1x | 0.7x |
| Mon, 09 Oct 2023 | PK₨142.4b | PK₨238.0b | PK₨8.2b | 11.4x | 17.3x | 0.6x |
| Wed, 06 Sep 2023 | PK₨138.1b | PK₨234.0b | PK₨9.9b | 10.3x | 13.9x | 0.6x |
| Fri, 04 Aug 2023 | PK₨162.9b | PK₨230.3b | PK₨10.4b | 12.9x | 15.6x | 0.7x |
| Sun, 02 Jul 2023 | PK₨143.1b | PK₨230.3b | PK₨10.4b | 11.7x | 13.7x | 0.6x |
| Tue, 30 May 2023 | PK₨150.6b | PK₨228.3b | PK₨12.6b | 11.8x | 11.9x | 0.7x |
| Thu, 27 Apr 2023 | PK₨152.6b | PK₨217.4b | PK₨15.2b | 9.1x | 10x | 0.7x |
| Sat, 25 Mar 2023 | PK₨156.2b | PK₨214.7b | PK₨16.5b | 9.1x | 9.5x | 0.7x |
| Mon, 20 Feb 2023 | PK₨161.2b | PK₨211.8b | PK₨16.8b | 9x | 9.6x | 0.8x |
| Wed, 18 Jan 2023 | PK₨156.8b | PK₨211.8b | PK₨16.8b | 9.1x | 9.3x | 0.7x |
| Fri, 16 Dec 2022 | PK₨184.9b | PK₨210.9b | PK₨16.9b | 9.8x | 11x | 0.9x |
| Sun, 13 Nov 2022 | PK₨209.9b | PK₨208.9b | PK₨16.5b | 11.4x | 12.7x | 1x |
| Tue, 11 Oct 2022 | PK₨216.5b | PK₨201.6b | PK₨19.0b | 11.2x | 11.4x | 1.1x |
| Thu, 08 Sep 2022 | PK₨225.3b | PK₨193.0b | PK₨20.3b | 10.6x | 11.1x | 1.2x |
| Sat, 06 Aug 2022 | PK₨230.6b | PK₨189.9b | PK₨23.3b | 9.9x | 9.9x | 1.2x |
| Mon, 04 Jul 2022 | PK₨238.3b | PK₨188.5b | PK₨23.1b | 10.2x | 10.3x | 1.3x |
| Wed, 01 Jun 2022 | PK₨228.2b | PK₨184.3b | PK₨22.9b | 9.3x | 10x | 1.2x |
| Fri, 29 Apr 2022 | PK₨249.4b | PK₨183.4b | PK₨23.0b | 9.8x | 10.9x | 1.4x |
| Sun, 27 Mar 2022 | PK₨245.9b | PK₨181.2b | PK₨21.4b | 10.7x | 11.5x | 1.4x |
| Tue, 22 Feb 2022 | PK₨262.6b | PK₨180.0b | PK₨21.5b | 12x | 12.2x | 1.5x |
| Thu, 20 Jan 2022 | PK₨264.7b | PK₨180.0b | PK₨21.5b | 12.1x | 12.3x | 1.5x |
| Sat, 18 Dec 2021 | PK₨254.9b | PK₨180.0b | PK₨21.5b | 11.7x | 11.9x | 1.4x |
| Mon, 15 Nov 2021 | PK₨284.9b | PK₨179.9b | PK₨21.5b | 13.6x | 13.3x | 1.6x |
| Wed, 13 Oct 2021 | PK₨285.8b | PK₨173.6b | PK₨20.7b | 13.7x | 13.8x | 1.6x |
| Fri, 10 Sep 2021 | PK₨311.1b | PK₨170.6b | PK₨19.1b | 17.5x | 16.2x | 1.8x |
| Sun, 08 Aug 2021 | PK₨313.5b | PK₨170.6b | PK₨19.1b | 19.6x | 16.4x | 1.8x |
| Sat, 01 May 2021 | PK₨279.6b | PK₨157.5b | PK₨17.2b | 14.9x | 16.2x | 1.8x |
Price to Earnings Ratio
16.2x
Current Industry PE
- Investors are optimistic on the Pakistani Healthcare industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 25.1x which is higher than its 3-year average PE of 14.4x.
- The 3-year average PS ratio of 1.1x is higher than the industry's current PS ratio of 0.80x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have declined 22% per year over the last three years.
- Meanwhile revenues for these companies have grown 18% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the Pakistani Healthcare sector?
| PK Market | 0.97% | |
| Healthcare | 1.60% | |
| Pharma | 2.11% | |
| Medical Equipment | 0% | |
| Healthtech | 0% | |
| Biotech | 0% | |
| Healthcare Services | -0.78% | |
| Life Sciences | -9.33% | |
Industry PE
- Investors are most optimistic about the Life Sciences industry even though it's trading below its 3-year average PE ratio of 53.3x.
- It looks like they are confident that earnings will grow faster in the future than they have historically.
- Investors are most pessimistic about the Healthcare Services industry, which is trading below its 3-year average of 15.9x.
Forecasted Growth
- Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 38% over the next 5 years.
- This is better than its past earnings decline of 3.3% per year.
- In contrast, the Pharma industry is expected to see its earnings grow by 38% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| GLAXO GlaxoSmithKline Pakistan | PK₨98.89 | 9.2% +PK₨2.7b | 30.1% | PE59x | |
| ABOT Abbott Laboratories (Pakistan) | PK₨549.96 | 2.7% +PK₨1.4b | 37.5% | PE205.7x | |
| AGP AGP | PK₨81.56 | 4.6% +PK₨996.8m | 55.6% | PE14.6x | |
| HPL Hoechst Pakistan | PK₨1.40k | 7.7% +PK₨964.4m | 112.1% | PE37.4x | |
| OTSU Otsuka Pakistan | PK₨146.07 | 12.9% +PK₨201.9m | 90.5% | PE47.7x |